Comparison of Aneuploidy Risk Evaluations
NCT01663350 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2013-07-16
Summary
This is a prospective, multi-center observational study designed to compare the test results of the Verinata Health Prenatal Aneuploidy Test to results of conventional prenatal screening for fetal chromosome abnormalities in 'all-risk' pregnancies.
Conditions
- Pregnancy
- Down Syndrome
- Edwards Syndrome
- Patau Syndrome
- Turners Syndrome
Sponsors & Collaborators
-
Verinata Health, Inc.
lead INDUSTRY
Principal Investigators
-
Amy J Sehnert, MD · Verinata Health, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688 ·Status: COMPLETED
-
Automated Screen for Fetal Aneuploidy
NCT03635359 ·Status: UNKNOWN
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT02317965 ·Status: UNKNOWN
-
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
NCT01597063 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 ·Status: COMPLETED
-
Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
NCT00006445 ·Status: UNKNOWN ·Phase: NA
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346 ·Status: COMPLETED
-
Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation
NCT03552055 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
National Prevalence and Impact of Noninvasive Prenatal Testing
NCT02284399 ·Status: COMPLETED
-
A New Prenatal Blood Test for Down Syndrome
NCT00877292 ·Status: COMPLETED
-
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
NCT04595201 ·Status: RECRUITING
-
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852 ·Status: UNKNOWN
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
NCT03831256 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Performance of NIPT in Multiple Gestation Pregnancies
NCT04488393 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
VAlidation of a Lower Cost aneUploidy scrEen
NCT03087357 ·Status: COMPLETED
-
Clinical Evaluation of the IONA Test for Non-invasive Pre Natal Screening in Twin Pregnancies
NCT03200041 ·Status: COMPLETED ·Phase: NA
-
First Trimester Risk Assessment Based on Ultrasound and Cell-free DNA vs Combined Screening
NCT04077060 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
NCT02226315 ·Status: TERMINATED
-
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
NCT01404221 ·Status: TERMINATED